Dr Athanasios Gaitatzis joined the Perron Institute as a Consultant Neurologist and started his Epilepsy Clinic in early 2016. In late 2017, Dr Gaitatzis started a specialist Epilepsy and Pregnancy clinic, the first of its kind in Australia. He is also a Consultant in the Neurology Department at Sir Charles Gairdner Hospital. His Perron Institute Clinics are focused on the care of people with refractory (or drug-resistant) epilepsy, complex epilepsy (in people with neurodevelopmental or psychiatric comorbidities), and epilepsy in women (dealing with preconception counselling, pregnancy and breastfeeding issues).
Yuan J, Meloni BP, Shi T, Bonser A, Papadimitriou JM, Mastaglia FL, Zhang C, Zheng M, Gao J. The Potential Influence of Bone-derived Modulators on the Progression of Alzheimer’s Disease. Journal of Alzheimer’s Disease. 2019 Mar 22:1-2. doi: 10.3233/JAD-181249
MacDougall G, Anderton RS, Mastaglia FL, Knuckey NW, Meloni BP. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity. Mol Brain. 2019 Jul 17;12(1):66. doi: 10.1186/s13041-019-0486-8.
Edwards AB, Anderton RS, Knuckey NW, Meloni BP. (2018). Assessment of therapeutic window for poly-arginine-18D (R18D) in a P7 rat model of perinatal hypoxic-ischaemic encephalopathy. Journal of Neuroscience Research. In press.
Edwards AB, Anderton RS, Knuckey NW, Meloni BP. (2018). Review: Perinatal hypoxic-ischaemic encephalopathy and neuroprotective peptide therapies: a case for cationic arginine-rich peptides (CARPs). Brain Sciences. In press.
Milani D, Bakeberg MC, Cross JL, Clark VW, Anderton, RS, Blacker DJ, Knuckey NW, Meloni BP (2018). Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies. PlosOne 13(3): e0193884. https://doi.org/10.1371/journal.pone.0193884
Assessment of R18, COG1410, and APP96-110 in excitotoxicity and traumatic brain injury. Chiu LS, Anderton RS, Clark VW, Edwards AB, Knuckey NW, Meloni BP. (2017). Translational Neuroscience. DOI: https://doi.org/10.1515/tnsci-2017-0021
Delayed 2h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat. Milani, D, Cross, JL. Anderton, RS, Blacker, DJ, Knuckey, NW, Meloni, BP. (2017). Brain Research Bulletin 28, 135:62-68. DOI: 10.1016/j.brainresbull.2017.09.012
Neuroprotective efficacy of R18 poly-arginine and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat. Milani, D, Cross, JL, Anderton, RS, Blacker, DJ, Knuckey, NW, Meloni, BP 2017 Neuroscience Research 114:9-15
‘Investigation of poly-arginine peptide neuroprotective mechanisms using an in vitro neurotrauma injury model’. Meloni B, Knuckey N, Chiu L, Anderton R. $100,000. Neurotrauma Research Program.